In addition to ALDH being a CSC marker, inhibiting ALDH activity was found to block irradiation-induced stemness and decrease breast tumor growth and metastasis (18), which provided a rationale for utilizing it as a target for immunotherapy. The gene discussed is LDHA; the disease is breast neoplasm.